Background: Pruritus is a frequent symptom in many diseases; its prevalence in German adults is unknown. Objective: Our purpose was to assess the prevalence, severity and health care of chronic pruritus in the German working population. Methods: A cross-sectional observational study was conducted in employees of 144 German companies. Pruritus-specific data were obtained by standardized questions. Results: 11,730 people (53.2% male, 16–70 years, mean = 43.7 years) were suitable for analysis. The point prevalence of chronic pruritus (at least 6 weeks prior to data collection) was 16.8%. The prevalence increased with age from 12.3% (16–30 years) to 20.3% (61–70 years). A quarter of the affected persons had suffered from pruritus for >5 years, 47% had never sought medical advice, and 94% had not undergone any treatment. Conclusions: Chronic pruritus is a prevalent symptom in the working age population. A high proportion of people affected are not medically treated.

1.
Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M: The neurobiology of itch. Nat Rev Neurosci 2006;7:535–547.
2.
Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa N, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard J: Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol 2007;87:291–294.
3.
Wolkenstein P, Grob J, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J; Société Française de Dermotologie: French people and skin disease: results of a survey using a representative sample. Arch Dermatol 2003;139:1614–1619.
4.
Dalgard F, Svensson A, Holm JO, Sundby J: Self-reported skin morbidity in Oslo: associations with sociodemographic factors among adults in a cross-sectional study. Br J Dermatol 2004;151:452–457.
5.
Dalgard F, Dawn AG, Yosipovitch G: Are itch and chronic pain associated in adults? Results of a large population survey in Norway. Dermatology 2007;214:305–309.
6.
Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E: Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large sale studies. Acta Derm Venereol 2009;89:250–256.
7.
Schäfer I, Rustenbach SJ, Zimmer L, Augustin M: Prevalence of skin diseases in a cohort of 48665 employees in Germany. Dermatology 2008;217:169–172.
8.
Sommer F, Hensen P, Böckenholt B, Metze D, Luger TA, Ständer S: Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007;87:510–516.
9.
Savin A, Paterson WD, Oswald I: Scratching during sleep. Lancet 1973;2:296–297.
10.
Sack R, Hanifin J: Scratching below the surface of sleep and itch. Sleep Med Rev 2010, Epub ahead of print.
11.
Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE: Specific C-receptors for itch in human skin. J Neurosci 1997;17:8003–8008.
12.
Andrew D, Craig AD: Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001;4:72–77.
13.
Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411–417.
14.
Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF: Cellular basis of itch sensation. Science 2009;325:1531–1534.
15.
Ständer S, Weisshaar E, Luger TA: Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008;17:161–169.
16.
Ständer S, Streit M, Darsow U, Niemeier V, Vogelgsang M, Ständer H, Gieler U, Gollnick H, Metze D, Weisshaar E: Leitlinie: diagnostisches und therapeutisches Vorgehen bei chronischem Pruritus. J Dtsch Dermatol Ges 2006;4:350–370.
17.
Szepietowski J, Reich A, Wisnicka B: Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 2002;10:221–226.
18.
Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL, Gollnick H: Pruritus as a leading symptom: clinical characterstics and quality of life in German and Ugandan patients. Br J Dermatol 2006;155:957–964.
19.
Proske S, Hartschuh W: Anal pruritus; in Misery L, Ständer S (eds): Pruritus. Berlin, Springer, 2010.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.